All News #Library
Biotech
BioVaxys Licensee Reports Positive SpayVac Single-Dose Efficacy
14 Oct 2025 //
PR NEWSWIRE
Biovaxys Appoints Former Sanofi Vaccines Executive to Board
08 Oct 2025 //
PR NEWSWIRE
Biovaxys Announces Amended Life Offering
19 Jun 2025 //
PR NEWSWIRE
BioVaxys & Sona Nanotech Enter Research Collaboration
07 May 2025 //
CONTRACTPHARMA
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
17 Mar 2025 //
PR NEWSWIRE
BioVaxys Developing DPX As Carrier Of Choice For mRNA Vaccines
16 Jan 2025 //
PR NEWSWIRE
BioVaxys Secures GMP-Grade Lipid Supply for DPX-Based Vaccines
17 Dec 2024 //
PR NEWSWIRE
BioVaxys Shares Data on DPX™ Immune Educating Platform
05 Dec 2024 //
PR NEWSWIRE
BioVaxys Partner SpayVac Scales Wildlife Vaccine Production
20 Nov 2024 //
PR NEWSWIRE
BioVaxys Joins BARDA Vaccine Development Consortium
05 Nov 2024 //
PR NEWSWIRE
BioVaxys Engages Dr. Rajagopalan As Vaccine Formulations Advisor
08 Oct 2024 //
PR NEWSWIRE
BioVaxys to Present DPX Immune Educating Platform Data at Cancer Vaccine Summit
04 Sep 2024 //
PR NEWSWIRE
BioVaxys DPX Vaccines Show Efficacy In Multiple Diseases
22 Aug 2024 //
PR NEWSWIRE
BioVaxys Acquires Intellectual Property of the Former IMV Inc.
12 Feb 2024 //
PR NEWSWIRE

Market Place
Sourcing Support